跳转至内容
Merck
所有图片(2)

主要文件

查看所有文档

S6322

Sigma-Aldrich

Sigma佐剂系统®

oil

别名:

Adjuvant System, Sigma Adjuvant

登录查看公司和协议定价

选择尺寸

1 VIAL
$481.00

$481.00

预计发货时间2025年4月14日详情

获取大包装报价
所有图片(2)

选择尺寸

变更视图
1 VIAL
$481.00

About This Item

UNSPSC代码:
12352203
NACRES:
NA.46

$481.00

预计发货时间2025年4月14日详情

获取大包装报价

表单

oil

质量水平

300

储存温度

2-8°C

应用

佐剂检测：测试小鼠的EIA滴度至少是对照小鼠的2倍。

生化/生理作用

Sigma Adjuvant System是一种稳定的水包油乳液，可作为弗氏′经典油包水乳液的一种替代品。它衍生自细菌和分枝杆菌细胞壁中可为免疫系统提供有效刺激的成分。

外形

在每小瓶中的2％油（角鲨烯）-Tween® 80-水中含有0.5 mg来自明尼苏达沙门氏菌的单磷酰脂质A（脱毒内毒素）以及0.5 mg合成海藻糖二十二烷酸酯。

法律信息

Sigma Adjuvant System is a registered trademark of Merck KGaA, Darmstadt, Germany
TWEEN is a registered trademark of Croda International PLC

免责声明

除非我们的产品目录或产品附带的其他公司文档另有说明，否则我们的产品仅供研究使用，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。

相关产品

产品编号
说明
价格

象形图

Health hazard
GHS08

警示用语：

Danger

危险声明

H304

危险分类

Asp. Tox. 1

储存分类代码

10 - Combustible liquids

WGK

WGK 2

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
0000407553
0000407553
0000329924
0000235360
0000329924

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Déirdre B Ní Eidhin et al.
FEMS immunology and medical microbiology, 52(2), 207-218 (2007-12-21)
Clostridium difficile is the leading cause of infectious antibiotic-associated diarrhoea, particularly among the elderly. Its surface-layer protein (SLP) was tested as a vaccine component in a series of immunization and challenge experiments with Golden Syrian hamsters, combined with different systemic
Nadja Thönes et al.
Journal of virology, 82(11), 5472-5485 (2008-04-04)
Capsomeres are considered to be an alternative to viruslike particle (VLP)-based vaccines as they can be produced in prokaryotic expression systems. So far, no detailed side-by-side comparison of VLPs and capsomeres has been performed. In the present study, we immunized
Avi-Hai Hovav et al.
Infection and immunity, 73(1), 250-257 (2004-12-25)
In this study, we examined the immunogenicity and protective efficacy of six immunodominant Mycobacterium tuberculosis recombinant antigens (85B, 38kDa, ESAT-6, CFP21, Mtb8.4, and 16kDa) in a multivalent vaccine preparation (6Ag). Gamma interferon (IFN-gamma) and monophosphoryl lipid A-trehalose dicorynomycolate (Ribi) adjuvant
Christina Schellenbacher et al.
Journal of virology, 83(19), 10085-10095 (2009-07-31)
The amino (N) terminus of the human papillomavirus (HPV) minor capsid protein L2 can induce low-titer, cross-neutralizing antibodies. The aim of this study was to improve immunogenicity of L2 peptides by surface display on highly ordered, self-assembled virus-like particles (VLP)
Development of monoclonal antibodies specific for Ricinus agglutinins
Brandon DL and Hernlem BJ
Food and agricultural immunology, 20(1), 11-22 (2009)
查看所有相关文献

商品

An Introduction to Antibodies: Antigens, Epitopes and Antibodies

Antibodies combine with specific antigens to generate an exclusive antibody-antigen complex. Learn about the nature of this bond and its use as a molecular tag for research.

抗体简介：抗原、表位和抗体

抗体可与特定的抗原结合，产生独特的抗体-抗原复合物。本文讨论这一连接键的性质，以及其作为分子标签的研究应用。

相关内容

Antibody Support Reagents

Access high-quality reagents for antibody workflows, including adjuvants, blocking reagents, conjugation kits, and more.

Questions

1–8 of 8 Questions  

  1. Is the adjuvant ready to use? I don't see any mention in the datasheet on how to prepare the Antigen:adjuvant mixture. Can you help with that? Thank you.

    1 answer

    1. This product requires dilution with saline prior to use. This dilution can be done with or without the addition of the antigen. See below for a brief protocol.

      Prior to antigen addition, warm contents of vial to 40-45 °C. Add 2.0 mL of sterile saline containing the desired amount of antigen.
      The final emulsion will contain a concentration of 2% oil.
      1. Inject antigen-saline solution (2 mL) directly into the vial through the rubber stopper using a syringe fitted with a 20 or 21-gauge needle (leave the cap seal in place).
      2. Vortex the vial vigorously for 2 to 3 minutes to form emulsion. Invert the vial and vortex for 1 minute to ensure reconstitution of any product adhering to the stopper.
      3. If the entire contents of the vial will not be used initially, reconstitute with 1 ml saline without antigen. This emulsion can be stored at 2-8 °C for up to 60 days. Do Not freeze.
      To use, mix aliquots 1:1 with antigen in saline.
      4. Prior to inoculation, warm the vial to 37 °C and vortex briefly.

      For full details on injection protocols and boosting, please navigate to the link https://www.sigmaaldrich.com/techservice, click on "Product Technical Inquiries" under the Products Section with all the required information so that a member of the Technical Service team can reach out to assist further. Thank you.

      Helpful?

  2. What is the Department of Transportation shipping information for this product?

    1 answer

    1. Transportation information can be found in Section 14 of the product's (M)SDS.To access the shipping information for this material, use the link on the product detail page for the product.

      Helpful?

  3. When using the Sigma Adjuvant System® reagent, Product No. S6322, how do the components MPL and TDM work as an adjuvant?

    1 answer

    1. MPL (monophosphoryl lipid A) will bind to CD14 on the cell surface similar to LPS.  TDM (trehalose dicorynomycolate) is an analog of one of the components of the tubercle bacillus. Both of these components act like a superantigen and activate the immune system nonspecifically.  This allows for a greater response to the immunogen delivered in this adjuvant.

      Helpful?

  4. Can you reconstitute and store the Sigma Adjuvant System® reagent (Product No. S6322) if not using the entire vial right away?

    1 answer

    1. If the entire contents of the vial will not be used initially, reconstitute with 1 ml saline without antigen.  This emulsion can then be stored at 2-8 °C for up to 60 days.  Do Not Freeze. To use, mix aliquots 1:1 with antigen in saline. Prior to inoculation, warm the vial to 37 °C and vortex briefly.  This and other information can be found on the Sigma Adjuvant System® reagent (Product No. S6322) Product Information Sheet.

      Helpful?

  5. What is used to solubilize Product No. S6322, Sigma Adjuvant System® reagent?

    1 answer

    1. The Sigma Adjuvant System® reagent (Product No. S6322) can be solubilized in a sterile saline solution containing the desired amount of antigen to a final volume of 2 ml.  For more details, please see the S6322 Product Information Sheet.

      Helpful?

  6. Is the Sigma Adjuvant System®, Product No S6322, the same as the RIBI adjuvant?

    1 answer

    1. Yes, the Sigma Adjuvant System®, Product No S6322, is also called RIBI adjuvant.

      Helpful?

  7. Has Sigma Adjuvant System®, Product S6322, been used to induce EAE (Experimental autoimmune encephalomyelitis)?

    1 answer

    1. Sigma Adjuvant System®, Product S6322 is a replacement for MPT+TDM adjuvant (Ribi, Product M6536) that was discontinued by the supplier Corixa.  Although we have not tested Product S6322 for induction of Experimental autoimmune encephalomyelitis (EAE), the following reference cites the use of MBP in Ribi adjuvant for induction of acute EAE.The Journal of ImmunologyOctober 15, 2005, 175(8): 5077-5086

      Helpful?

  8. When using the Sigma Adjuvant System®, Product No. S6322, how is the antigenic response boosted?

    1 answer

    1. With the Sigma Adjuvant System® (Product No. S6322) with mice, rabbits, rats and guinea pigs; boost on day 21 or 28, bleed 10 - 14 days after booster injection. Boost every 3 - 4 weeks thereafter. For goats; boost every four weeks. Use the same protocol for each injection.  For more information please see the Product Information Sheet for Product No. S6322.

      Helpful?

Reviews

No rating value

Active Filters

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持